Category
Promote Healthy People, Healthy Planet and Improve Care for All

The Gillings Community Responds to COVID-19: Tracking the Spread

May 18, 2020
The asymptomatic transmission of COVID-19 has created a significant challenge for public health experts. Learn how faculty and alumni in epidemiology, health behavior and biostatistics are working to track the spread of the disease through studies, contact tracing, modeling and more.

Gillings researchers advance in the quest for a dengue vaccine

May 13, 2020
Dengue viruses are estimated to cause ~390 million infections and 100 million cases each year around the globe. Because infection with one of the four unique dengue strains does not provide lasting immunity to the other strains, it has been especially difficult to create an effective vaccine.

The Gillings Community Responds to COVID-19: Keeping Communities Informed

May 11, 2020
The digital space has made information about COVID-19 more accessible than ever – but not more accurate. Students in maternal and child health, the Public Health Leadership Program and environmental sciences and engineering are generating solutions to communicate public health information factually and effectively to communities in need.

Adults in Mexico are consuming fewer soft drinks three years into a sugary-beverage tax

May 6, 2020
“These results show that the tax is lowering the consumption of sugar-sweetened drinks among an adult cohort over the first three-years of the tax implementation,” says Dr. Shu Wen Ng. “In particular, it lowered the proportion of medium and high consumers of the beverages, while increasing the share of adults who were low-consumers and non-consumers.”

The Gillings Community Responds to COVID-19: Voices from the Front Lines

May 4, 2020
During the COVID-19 pandemic, many Gillings School students and alumni across North Carolina are doing tireless work on the front lines in response to surging health care needs. Students and alumni from health policy and management, the Public Health Leadership Program and health behavior share their stories and experiences.

Remdesivir, developed through a UNC-Chapel Hill partnership, proves effective against COVID-19 in NIAID human clinical trials

April 29, 2020
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, reported that data from an international clinical trial testing the broad-spectrum antiviral drug remdesivir showed “quite good news” and should result in a new standard of care for COVID-19 patients. Remdesivir was co-developed by researchers in the Baric Lab at the UNC Gillings School of Global Public Health.

Human rights play a critical role in the development of COVID-19 health policies

April 29, 2020
Governments worldwide have implemented policies in an effort to mitigate the worst effects of the coronavirus pandemic, but the extent to which these policies constrain individual rights has been overlooked, according to Dr. Benjamin Mason Meier. This can have a detrimental impact on the world’s most vulnerable populations.